Researchers at the Mayo Clinic in Rochester, Minnesota have completed the first whole exome sequence of small intestine neuroendocrine tumors and have identified six pathways as potential drug targets for these NETs. Read more about the Mayo Clinic research here. Click here for the full text article. And learn more about exome sequencing.
